Evaxion A/S Files Form 6-K for September 2025
Ticker: EVAX · Form: 6-K · Filed: Sep 25, 2025 · CIK: 1828253
| Field | Detail |
|---|---|
| Company | Evaxion A/S (EVAX) |
| Form Type | 6-K |
| Filed Date | Sep 25, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, form-6k
Related Tickers: EVX
TL;DR
EVX filed a 6-K, looks like they're submitting their 20-F.
AI Summary
Evaxion A/S, a biotechnology company, filed a Form 6-K on September 25, 2025. This report is for the month of September 2025 and indicates the company is submitting its annual report under Form 20-F. Evaxion A/S is incorporated in G7 and its fiscal year ends on December 31.
Why It Matters
This filing indicates Evaxion A/S is fulfilling its reporting obligations as a foreign private issuer, which is crucial for maintaining its listing and providing transparency to investors.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material financial or operational information that would inherently increase risk.
Key Numbers
- 001-39950 — Commission File Number (Identifies the specific SEC filing registration)
Key Players & Entities
- Evaxion A/S (company) — Registrant
- 001-39950 (dollar_amount) — Commission File Number
- 20250925 (date) — Filing Date
- September 2025 (date) — Reporting Period
- Form 20-F (company) — Annual Report Form
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report information for the month of September 2025 and to indicate that the registrant is submitting its annual report under cover of Form 20-F.
What is Evaxion A/S's fiscal year end?
Evaxion A/S's fiscal year ends on December 31.
Where is Evaxion A/S's principal executive office located?
Evaxion A/S's principal executive office is located at Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark.
What is the SIC code for Evaxion A/S?
The Standard Industrial Classification (SIC) code for Evaxion A/S is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Has Evaxion A/S previously operated under a different name?
Yes, Evaxion A/S was formerly known as Evaxion Biotech A/S, with a date of name change on October 14, 2020.
Filing Stats: 302 words · 1 min read · ~1 pages · Grade level 10.1 · Accepted 2025-09-25 07:15:06
Filing Documents
- f6k_092525.htm (6-K) — 7KB
- exh_991.htm (EX-99.1) — 9KB
- 0001171843-25-006068.txt ( ) — 17KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Evaxion A/S (Registrant) Date: September 25, 2025 By: /s/ Birgitte Rn Birgitte Rn Interim Chief Executive Officer